CNBX Pharmaceuticals Inc Sustainability Reports
A clinical-stage biopharmaceutical company that discovers, develops, and commercializes cannabinoid-based products and technologies for the treatment of cancer.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300VXUG36I0WVN749
FIGI: BBG001SRQ455
No reports are currently available in our catalogue.